Litcius/Paper detail

Laser-responsive erastin-loaded chondroitin sulfate nanomedicine targeting CD44 and system xc− in liver cancer: A non-ferroptotic approach

So‐Yeol Yoo, Hyun-Young Kim, Dong‐Hyun Kim, Wan Seob Shim, Sang‐Min Lee, Dong Hwan Lee, Jang Mo Koo, Ji Hoon Yoo, Seokjin Koh, Jong‐Chan Park, Jieun Yu, Jang Su Jeon, Min‐Jun Baek, Dae-Duk Kim, Ji-Yoon Lee, Ji-Yoon Lee, Soo Jin Oh, Sang Kyum Kim, Jae‐Young Lee, Jae‐Young Lee, Keon Wook Kang

2024Journal of Controlled Release11 citationsDOI

Topics & Concepts

NanomedicineCD44Chondroitin sulfateCancer researchCancerMedicineChemistryGlycosaminoglycanNanotechnologyInternal medicineNanoparticleMaterials scienceBiochemistryCellFerroptosis and cancer prognosisLipid metabolism and biosynthesisCaveolin-1 and cellular processes
Laser-responsive erastin-loaded chondroitin sulfate nanomedicine targeting CD44 and system xc− in liver cancer: A non-ferroptotic approach | Litcius